Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
- PMID: 17632003
- DOI: 10.1016/j.bmcl.2007.06.072
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
Abstract
A novel series of heterocycle-based analogs were prepared and evaluated for their in vitro and in vivo biological activity as human beta(3)-adrenergic receptor (AR) agonists. Several analogs demonstrated potent agonist activity at the beta(3)-AR, functional selectivity against beta(1)- and beta(2)-ARs, and favorable pharmacokinetic profiles in vivo. Compound 17 increased oxygen consumption in rats, a measure of energy expenditure, with an ED(20%) of 2mg/kg.
Similar articles
-
Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.Bioorg Med Chem Lett. 2005 Jan 17;15(2):251-4. doi: 10.1016/j.bmcl.2004.11.001. Bioorg Med Chem Lett. 2005. PMID: 15603933
-
Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.Eur J Med Chem. 2009 Jun;44(6):2533-43. doi: 10.1016/j.ejmech.2009.01.022. Epub 2009 Jan 31. Eur J Med Chem. 2009. PMID: 19232786
-
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.J Med Chem. 2008 Mar 27;51(6):1925-44. doi: 10.1021/jm701324c. Epub 2008 Feb 29. J Med Chem. 2008. PMID: 18307290
-
The use of beta3-adrenergic receptor agonists in the treatment of heart failure.Curr Opin Investig Drugs. 2009 Sep;10(9):955-62. Curr Opin Investig Drugs. 2009. PMID: 19705338 Review.
-
Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes.Int J Obes Relat Metab Disord. 1996 Mar;20(3):191-9. Int J Obes Relat Metab Disord. 1996. PMID: 8653138 Review.
Cited by
-
Induction of Adipose Tissue Browning as a Strategy to Combat Obesity.Int J Mol Sci. 2020 Aug 28;21(17):6241. doi: 10.3390/ijms21176241. Int J Mol Sci. 2020. PMID: 32872317 Free PMC article. Review.
-
Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity.Diabetologia. 2015 May;58(5):1045-54. doi: 10.1007/s00125-015-3543-6. Epub 2015 Mar 1. Diabetologia. 2015. PMID: 25725625 Clinical Trial.
-
Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.Mol Divers. 2011 Nov;15(4):817-31. doi: 10.1007/s11030-011-9311-8. Epub 2011 Mar 20. Mol Divers. 2011. PMID: 21424594
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Medical
Research Materials